Endozepine stupor. Recurring stupor linked to endozepine-4 accumulation

Elio Lugaresi, Pasquale Montagna, Paolo Tinuper, Giuseppe Plazzi, Roberto Gallassi, Tau Chin L Wang, Sanford P. Markey, Jeffrey D Rothstein

Research output: Contribution to journalArticle

Abstract

Recurring stupor can be caused by repeated metabolic, toxic or structural brain disturbances. Recently, cases of recurring stupor with fast EEG activity were shown to display increased endogenous benzodiazepine-like activity during the episodes of stupor. Patients with recurring stupor underwent extensive metabolic and toxicologic screening, EEG and brain imaging. Endozepines and exogenously administered benzodiazepines were assayed in plasma and CSF by means of mass spectrometry. Flumazenil, a benzodiazepine antagonist was administered and the behavioural and EEG responses monitored. Treatment with oral flumazenil was attempted in selected cases. Twenty patients were found with recurring stupor. Episodes had begun between ages 18 and 67 years, and in nine patients, had disappeared spontaneously after 4-6 years with symptoms. Stupor lasted hours or days. Onset of the episodes and frequency were unpredictable. Patients were normal between attacks. Stupor was characterized by initial drowsiness, staggering and behavioural changes, followed by deep sleep and spontaneous recovery with post-ictal amnesia. Biochemical screening and brain imaging were always normal. Ictal EEG showed fast background activity, and flumazenil transiently awoke the patients and normalized the EEG. In the nine cases examined, endozepine-4 levels were increased during the stupor. Oral flumazenil reduced the frequency of the attacks in three of these nine patients. Recurring episodes of stupor may be due to increased endozepine-4. We propose the term 'endozepine stupor' for the benzodiazepine recognition site at the GABA(A) receptor, with unknown molecular structure.

Original languageEnglish (US)
Pages (from-to)127-133
Number of pages7
JournalBrain
Volume121
Issue number1
DOIs
StatePublished - Jan 1998

Fingerprint

Diazepam Binding Inhibitor
Stupor
Flumazenil
Electroencephalography
Benzodiazepines
Neuroimaging
Anterograde Amnesia
Sleep Stages
Poisons
GABA-A Receptors
Molecular Structure
Mass Spectrometry
Sleep

Keywords

  • Benzodiazepine
  • Coma
  • Endozepine
  • Flumazenil
  • Stupor

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Lugaresi, E., Montagna, P., Tinuper, P., Plazzi, G., Gallassi, R., Wang, T. C. L., ... Rothstein, J. D. (1998). Endozepine stupor. Recurring stupor linked to endozepine-4 accumulation. Brain, 121(1), 127-133. https://doi.org/10.1093/brain/121.1.127

Endozepine stupor. Recurring stupor linked to endozepine-4 accumulation. / Lugaresi, Elio; Montagna, Pasquale; Tinuper, Paolo; Plazzi, Giuseppe; Gallassi, Roberto; Wang, Tau Chin L; Markey, Sanford P.; Rothstein, Jeffrey D.

In: Brain, Vol. 121, No. 1, 01.1998, p. 127-133.

Research output: Contribution to journalArticle

Lugaresi, E, Montagna, P, Tinuper, P, Plazzi, G, Gallassi, R, Wang, TCL, Markey, SP & Rothstein, JD 1998, 'Endozepine stupor. Recurring stupor linked to endozepine-4 accumulation', Brain, vol. 121, no. 1, pp. 127-133. https://doi.org/10.1093/brain/121.1.127
Lugaresi E, Montagna P, Tinuper P, Plazzi G, Gallassi R, Wang TCL et al. Endozepine stupor. Recurring stupor linked to endozepine-4 accumulation. Brain. 1998 Jan;121(1):127-133. https://doi.org/10.1093/brain/121.1.127
Lugaresi, Elio ; Montagna, Pasquale ; Tinuper, Paolo ; Plazzi, Giuseppe ; Gallassi, Roberto ; Wang, Tau Chin L ; Markey, Sanford P. ; Rothstein, Jeffrey D. / Endozepine stupor. Recurring stupor linked to endozepine-4 accumulation. In: Brain. 1998 ; Vol. 121, No. 1. pp. 127-133.
@article{08f414cf610e41c7b7d218011e7e025c,
title = "Endozepine stupor. Recurring stupor linked to endozepine-4 accumulation",
abstract = "Recurring stupor can be caused by repeated metabolic, toxic or structural brain disturbances. Recently, cases of recurring stupor with fast EEG activity were shown to display increased endogenous benzodiazepine-like activity during the episodes of stupor. Patients with recurring stupor underwent extensive metabolic and toxicologic screening, EEG and brain imaging. Endozepines and exogenously administered benzodiazepines were assayed in plasma and CSF by means of mass spectrometry. Flumazenil, a benzodiazepine antagonist was administered and the behavioural and EEG responses monitored. Treatment with oral flumazenil was attempted in selected cases. Twenty patients were found with recurring stupor. Episodes had begun between ages 18 and 67 years, and in nine patients, had disappeared spontaneously after 4-6 years with symptoms. Stupor lasted hours or days. Onset of the episodes and frequency were unpredictable. Patients were normal between attacks. Stupor was characterized by initial drowsiness, staggering and behavioural changes, followed by deep sleep and spontaneous recovery with post-ictal amnesia. Biochemical screening and brain imaging were always normal. Ictal EEG showed fast background activity, and flumazenil transiently awoke the patients and normalized the EEG. In the nine cases examined, endozepine-4 levels were increased during the stupor. Oral flumazenil reduced the frequency of the attacks in three of these nine patients. Recurring episodes of stupor may be due to increased endozepine-4. We propose the term 'endozepine stupor' for the benzodiazepine recognition site at the GABA(A) receptor, with unknown molecular structure.",
keywords = "Benzodiazepine, Coma, Endozepine, Flumazenil, Stupor",
author = "Elio Lugaresi and Pasquale Montagna and Paolo Tinuper and Giuseppe Plazzi and Roberto Gallassi and Wang, {Tau Chin L} and Markey, {Sanford P.} and Rothstein, {Jeffrey D}",
year = "1998",
month = "1",
doi = "10.1093/brain/121.1.127",
language = "English (US)",
volume = "121",
pages = "127--133",
journal = "Brain",
issn = "0006-8950",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Endozepine stupor. Recurring stupor linked to endozepine-4 accumulation

AU - Lugaresi, Elio

AU - Montagna, Pasquale

AU - Tinuper, Paolo

AU - Plazzi, Giuseppe

AU - Gallassi, Roberto

AU - Wang, Tau Chin L

AU - Markey, Sanford P.

AU - Rothstein, Jeffrey D

PY - 1998/1

Y1 - 1998/1

N2 - Recurring stupor can be caused by repeated metabolic, toxic or structural brain disturbances. Recently, cases of recurring stupor with fast EEG activity were shown to display increased endogenous benzodiazepine-like activity during the episodes of stupor. Patients with recurring stupor underwent extensive metabolic and toxicologic screening, EEG and brain imaging. Endozepines and exogenously administered benzodiazepines were assayed in plasma and CSF by means of mass spectrometry. Flumazenil, a benzodiazepine antagonist was administered and the behavioural and EEG responses monitored. Treatment with oral flumazenil was attempted in selected cases. Twenty patients were found with recurring stupor. Episodes had begun between ages 18 and 67 years, and in nine patients, had disappeared spontaneously after 4-6 years with symptoms. Stupor lasted hours or days. Onset of the episodes and frequency were unpredictable. Patients were normal between attacks. Stupor was characterized by initial drowsiness, staggering and behavioural changes, followed by deep sleep and spontaneous recovery with post-ictal amnesia. Biochemical screening and brain imaging were always normal. Ictal EEG showed fast background activity, and flumazenil transiently awoke the patients and normalized the EEG. In the nine cases examined, endozepine-4 levels were increased during the stupor. Oral flumazenil reduced the frequency of the attacks in three of these nine patients. Recurring episodes of stupor may be due to increased endozepine-4. We propose the term 'endozepine stupor' for the benzodiazepine recognition site at the GABA(A) receptor, with unknown molecular structure.

AB - Recurring stupor can be caused by repeated metabolic, toxic or structural brain disturbances. Recently, cases of recurring stupor with fast EEG activity were shown to display increased endogenous benzodiazepine-like activity during the episodes of stupor. Patients with recurring stupor underwent extensive metabolic and toxicologic screening, EEG and brain imaging. Endozepines and exogenously administered benzodiazepines were assayed in plasma and CSF by means of mass spectrometry. Flumazenil, a benzodiazepine antagonist was administered and the behavioural and EEG responses monitored. Treatment with oral flumazenil was attempted in selected cases. Twenty patients were found with recurring stupor. Episodes had begun between ages 18 and 67 years, and in nine patients, had disappeared spontaneously after 4-6 years with symptoms. Stupor lasted hours or days. Onset of the episodes and frequency were unpredictable. Patients were normal between attacks. Stupor was characterized by initial drowsiness, staggering and behavioural changes, followed by deep sleep and spontaneous recovery with post-ictal amnesia. Biochemical screening and brain imaging were always normal. Ictal EEG showed fast background activity, and flumazenil transiently awoke the patients and normalized the EEG. In the nine cases examined, endozepine-4 levels were increased during the stupor. Oral flumazenil reduced the frequency of the attacks in three of these nine patients. Recurring episodes of stupor may be due to increased endozepine-4. We propose the term 'endozepine stupor' for the benzodiazepine recognition site at the GABA(A) receptor, with unknown molecular structure.

KW - Benzodiazepine

KW - Coma

KW - Endozepine

KW - Flumazenil

KW - Stupor

UR - http://www.scopus.com/inward/record.url?scp=0031983763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031983763&partnerID=8YFLogxK

U2 - 10.1093/brain/121.1.127

DO - 10.1093/brain/121.1.127

M3 - Article

C2 - 9549493

AN - SCOPUS:0031983763

VL - 121

SP - 127

EP - 133

JO - Brain

JF - Brain

SN - 0006-8950

IS - 1

ER -